Not all people with COVID-19 will require medical attention or treatment, and most recover within two weeks.
For mild cases, treatment focuses on managing symptoms. The U.S. Food and Drug Administration (FDA) has authorized several antibody therapies (also referred to as monoclonal antibodies) for use in people who are at high risk for being hospitalized or developing severe illness. For more information, visit the FDA website. If you’re experiencing COVID-19 symptoms, be sure to follow up with your healthcare provider about your treatment options.